Evidence map›Paper›PMID 25734378›Full record

ReviewACS chemical neuroscience2015

Epigenetic Mechanisms of Serotonin Signaling.

Terrell Holloway, Javier González-Maeso

Abstract readReview
In one paragraph

Review in ACS chemical neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia.International journal of molecular sciences · 2025
    Review
  6. 5-HTPharmacological reviews · 2025
    Review
  7. Role of Serotonin in Cadmium Mitigation in Plants.Plants (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. eLife · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Terrell Holloway†Department of Psychiatry, ‡Department of Neurology, and §Friedman Brain Institute, Icahn School of Medicine at Mount Sinai New York, New York 10029, United States.
Javier González-Maeso†Department of Psychiatry, ‡Department of Neurology, and §Friedman Brain Institute, Icahn School of Medicine at Mount Sinai New York, New York 10029, United States.
Icahn School of Medicine at Mount Sinai · US

Funding

Structure and function of the 5HT2A/mGluR2 complex in schizophreniaR01MH084894 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI Javier Gonzalez-Maeso · 2009 to 2026
$6.8M
NIMH NIH HHS R01 MH084894NIMH NIH HHS R01MH084894
6 · The paper itself

Abstract

Histone modifications and DNA methylation represent central dynamic and reversible processes that regulate gene expression and contribute to cellular phenotypes. These epigenetic marks have been shown to play fundamental roles in a diverse set of signaling and behavioral outcomes. Serotonin is a monoamine that regulates numerous physiological responses including those in the central nervous system. The cardinal signal transduction mechanisms via serotonin and its receptors are well established, but fundamental questions regarding complex interactions between the serotonin system and heritable epigenetic modifications that exert control on gene function remain a topic of intense research and debate. This review focuses on recent advances and contributions to our understanding of epigenetic mechanisms of serotonin receptor-dependent signaling, with focus on psychiatric disorders such as schizophrenia and depression.

Indexed as

Epigenesis, GeneticAnimalsBrainHumansReceptors, SerotoninSchizophreniaSerotoninReceptors, SerotoninSerotoninantipsychoticsepigeneticsG protein-coupled receptors (GPCRs)hallucinogenshistone deacetylases (HDACs)lysergic acid diethylamide (LSD)psychosisSchizophreniaserotonin 5-HT2A receptor

Identifiers

PMID25734378
PMCPMC4838281
OpenAlexW2028798936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.